| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-09-30 FY |
|---|---|---|---|---|---|---|
| Revenue | $391.98M | $410.18M | $375.05M | $321.74M | $57.25M | $151.04M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | $133.28M | $153.69M | $171.89M | $203.52M | $33.36M | $59.88M |
| Interest Expense | $28.31M | $31.41M | $31.82M | $1.09M | $896.00K | $4.53M |
| Tax Expense | $48.12M | $28.07M | $34.46M | $32.84M | $5.87M | $13.02M |
| Net Income | $160.84M | $88.90M | $111.59M | $118.01M | $21.40M | -$65.67M |
| EPS (basic) | 7.6100 | 4.2900 | 5.6600 | 6.0400 | 1.1000 | -4.1900 |
| EPS (diluted) | 7.5900 | 4.2600 | 5.5800 | 5.9900 | 1.0900 | -4.1900 |
| Shares (diluted) | $21.19M | $20.88M | $20.00M | $19.69M | $19.57M | $16.02M |